Aclarubicin disrupts RNA polymerase II progression at replication-coupled histone genes
Preprint
Abstract
Anthracyclines are effective chemotherapeutic agents that cause DNA and chromatin damage. One member of the anthracyclines, aclarubicin, has gained therapeutic interest due to its ability to kill cancer cells through chromatin-based mechanisms, thus avoiding the off-target effects associated with DNA damage. However, the molecular mechanism of action leading to aclarubicin-induced chromatin damage remains elusive. Here we performed Cleavage Under Targets and Tagmentation (CUT&Tag) of RNA polymerase II (Pol II) and other transcriptional regulators in human cells following aclarubicin treatment. We found that aclarubicin strongly disrupts the replication-coupled histone genes, resulting in a nonproductive accumulation of Pol II transcription machinery here beyond the levels at other genes. We attribute this sensitivity to the dense Pol II loading and rapid transcription of the histone genes, which intensify the chromatin-disrupting effects of aclarubicin. Together, our findings shed light on the mechanism of aclarubicin as an anticancer drug and point to the replication-coupled histone genes as a target for therapeutic intervention.Keywords
This publication has 71 references indexed in Scilit:
- Sequential RNA polymerase II activation drives human hematopoiesisCell Reports, 2026
- DNA intercalating drugs: Mechanisms of action in cancer treatmentAdvances in Biological Regulation, 2025
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- Biochemical and biophysical properties of positively supercoiled DNABiophysical Chemistry, 2017
- RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient TranscriptionCell, 2016
- BEDTools: The Swiss‐Army Tool for Genome Feature AnalysisCurrent Protocols in Bioinformatics, 2014
- Doxorubicin, DNA torsion, and chromatin dynamicsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- Doxorubicin Enhances Nucleosome Turnover around PromotersCurrent Biology, 2013
- Progression through the RNA Polymerase II CTD CycleMolecular Cell, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009